Associate Director, EU Lead/ Global Regulatory Lead, Bone Metabolism and Rare Oncology
AstraZeneca Rare Diseases, Alexion
PARIS, Ile-de-France, France
Charlie Mortazavi, PharmD, currently serves as an Associate Director, Global Regulatory Affairs at Alexion. Throughout his time at Alexion, Charlie has held global regulatory strategic oversight of registration and lifecycle management of Alexion rare metabolic diseases and rare oncology portfolio. With over 15 years of experience in global regulatory affairs, Charlie is recognized for having strategically led and executed project and portfolio strategies across a diverse range of therapeutic areas..
Disclosure information not submitted.
Wednesday, May 14, 2025
10:45 - 11:45 CEST
Patient-focused Drug Development in EU: From EPAR to Smpc?
Thursday, May 15, 2025
10:45 - 11:45 CEST
Thursday, May 15, 2025
14:30 - 15:30 CEST
The Value of Integrating Real-world and Trial Data to Increase Patient Benefit
Thursday, May 15, 2025
16:45 - 17:45 CEST